Steep Hill

About The Fund

Steep Hill is an investment firm with a focus on the burgeoning cannabis sector, alongside interests in healthcare, wellness, and life sciences. They offer medical cannabis testing and analytics services with an objective to measure the potency and safety of cannabinoid-infused products and medicines. Steep Hill utilizes premium instruments and qualified methodologies to analyze a wide range of components in its testing process. This includes the quantification of up to 20 cannabinoids, as many as 42 terpenes, and the identification of microbiological and pesticide contaminants as well as residual solvents. Through these comprehensive testing services, Steep Hill empowers cannabis cultivators and producers to enhance the transparency of the science behind their products, ensuring that they meet safety and quality standards. Their investment thesis seems to be rooted in the value proposition that a scientific and analytical approach to the cannabis industry is crucial for both product development and consumer confidence. By enabling clearer understanding and accountability within the cannabis market, Steep Hill's services support the development of reliable and standardized products within the healthcare and life science realms. In addition to the services they provide, Steep Hill is currently in the process of restructuring its business and is exploring strategic alternatives. The company has indicated that it has no operations in Canada or the US, highlighting its intent to reassess its operational footprint and potentially reorient its business strategy to better align with the evolving market and regulatory environments in the healthcare and cannabis sectors.